Drug Database
Back to search

Denmark· DK-28106487520

Ganirelix "Orifarm"

A ganirelix product containing ganirelixacetat, registered in Denmark by Orifarm Generics A/S. The same ATC class is registered in 17 of our 19 countries.

ATC H01CC01

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedGanirelix "Orifarm"ATCH01CC01REGISTER NO.DK-28106487520PACKS LISTED1CHECKEDSeptember 30, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ganirelixacetatAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Ganirelix is registered in 17 of 19 countries.

Countries holding a registration under ATC H01CC01 (ganirelix), each read from that country’s own register.

  • This record: Denmark, from Danish Medicines Agency (Denmark)
  • 10 of them publish a price we can compare per daily dose
Search ganirelix products by name

Ganirelix · ATC H01CC01

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Danish Medicines Agency (Denmark)
Active substance
Ganirelixacetat
Manufacturer
Orifarm Generics A/S
Country
Denmark (DK)
ATC code
H01CC01
ATC class
Ganirelix
Defined daily dose
0.25 mg, P
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28106487520

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

7 interactions on record for ganirelix.

Graded by severity as the source publishes them — 7 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check ganirelix against other medicinesHow interaction checks work

Ganirelix · interactions on record

7 records

  • 7 moderate

Most severe, free to view

  • Chorionic gonadotrophinG03GA01moderate
  • Menotropin HMGG03GA02moderate
  • UrofollitropinG03GA04moderate
  • GonadorelinH01CA01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under H01CC01

Ganirelix, as other registers publish it.

All ganirelix products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cb76009c-9eb9-4b26-b29d-976ca20a9a61
GET /v1/drugs/cb76009c-9eb9-4b26-b29d-976ca20a9a61?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "injektionsvæske, opløsning i fyldt injektionssprøjte",
  "source": "dkma",
  "strength": "0,25 mg/0,5 ml",
  "auth_role": "CMS",
  "dk_drugid": "28106487520",
  "substance": "Ganirelixacetat",
  "auth_procedure": "Decentral procedure",
  "in_medicinpriser": true,
  "registration_date_serial": "44509"
}
API referenceMCP serverPlans

See everything about ganirelix.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console